Matcha and diabetes: what the research shows

Matcha and diabetes is one of the most-searched matcha questions on the internet. The short answer: research links regular green tea drinking, including matcha, to improvements in fasting blood glucose, HbA1c and insulin sensitivity. The longer answer is more useful. Here it is, drawn from the most recent meta-analyses.

For most people with type 2 diabetes, yes, when matcha is part of a balanced diet and approved by their healthcare team.

A 2024 meta-analysis of 15 clinical trials covering 722 patients with type 2 diabetes found that green tea drinking significantly improved fasting blood glucose, HbA1c (the measure of average blood sugar over the past two to three months), and insulin resistance compared to control groups.

A separate 2024 meta-analysis of 41 randomised controlled trials looked specifically at EGCG, the most-studied catechin in matcha. It found modest but statistically significant reductions in fasting blood glucose, HbA1c and insulin resistance.

The effects are not dramatic. They are real, repeatable across studies, and consistent in direction. For people managing type 2 diabetes, matcha is a supportive addition. It is not a substitute for medication or medical care.

Yes, in small but measurable ways — through three mechanisms: slowing carbohydrate absorption, improving insulin sensitivity, and reducing oxidative stress.

Research suggests it can, in small but measurable ways. Three mechanisms come up repeatedly in the literature.

Slower glucose absorption

Catechins inhibit some of the enzymes that break down complex carbohydrates into simple sugars in the small intestine. Less rapid breakdown means a smaller spike in blood sugar after a meal containing carbs.

Improved insulin sensitivity

EGCG appears to help cells respond more efficiently to insulin. Glucose moves out of the bloodstream and into cells faster. A 2024 meta-analysis found that green tea drinking improved HOMA-IR, the standard measure of insulin resistance, with what researchers describe as a moderate effect.

Lower oxidative stress

Diabetes generates and is worsened by oxidative stress. Matcha is a concentrated source of antioxidants, which neutralise free radicals and reduce that stress. Over time, this may slow some of the downstream complications associated with diabetes.

Plain matcha does not raise blood sugar — it contains no carbohydrates or sugar. Sweeteners, syrups, and certain milks added to matcha are what affect blood sugar, not the powder itself.

Plain matcha does not raise blood sugar. With no carbohydrates and no sugar in the powder itself, there is nothing to spike. If anything, the research suggests matcha can modestly lower the blood sugar response to a meal eaten alongside it, by slowing the absorption of carbohydrates from food.

The only way matcha would raise your blood sugar is through what you add to it. Sweeteners, syrups, flavoured powders and the natural sugars in some milks all contribute. The matcha itself does not.

Pure matcha powder contains no sugar and negligible carbohydrates. Check the ingredients list — some blended products add sweeteners or palm sugar.

Pure matcha powder contains no sugar. A 2g serving has roughly 0g of sugar and minimal carbohydrates.

Not all matcha on the market is pure matcha. Some blends and supermarket products include palm sugar, sweeteners or other additives. Check the ingredients list. All Sipspa matcha is single-ingredient powder — no added sugar, no fillers, no sweeteners.

Milk is where most matcha drinkers get tripped up. Plant milks vary widely in carb and sugar content, and even unsweetened versions can be higher than you would expect. Oat milk is one to be aware of, because the processing that breaks down the oats creates natural sugars in the milk itself. If you are managing blood sugar, check the label on whichever milk you choose.

Population studies link habitual green tea consumption to lower rates of type 2 diabetes. Matcha is not a preventive treatment, but it is one of the few drinks consistently associated with better metabolic outcomes.

Long-term population studies have linked higher green tea consumption to lower rates of type 2 diabetes. The mechanisms behind that association are the same ones that help people already managing the condition: improvements in insulin sensitivity, glucose regulation, and inflammation.

Matcha is not a preventive treatment. It is one factor among many. Weight, activity level, genetics and the rest of your diet all matter more than any single drink. Within a broader healthy pattern, matcha is on the list of foods consistently associated with better metabolic outcomes.

Most of the clinical research on green tea and diabetes uses the equivalent of three to four servings of matcha a day. Each serving is 2g of powder. Some studies show benefits at lower doses of one to two servings.

If you already drink matcha, your usual amount is likely fine. If you are starting from zero, one or two servings a day is a sensible place to begin.

Most of the research on matcha and blood sugar looks at total daily consumption rather than timing. That said, the mechanisms suggest a useful pattern.

Catechins slow the absorption of carbohydrates from food. Drinking matcha with or shortly before a meal that contains carbs gives the catechins something to work on as the meal is digested. A serving with breakfast, or before a carb-heavier lunch, is a sensible default.

Spread your servings across the day rather than drinking them back to back. Two or three smaller doses over the course of a day give your body steadier exposure than one large one.

If you have diabetes or pre-diabetes, talk to your GP or diabetes educator before making meaningful changes to your diet. Matcha is generally safe, but it does contain caffeine, and some people on certain blood pressure or thyroid medications may need to be cautious about the amount.

This article is research-backed information, not medical advice.

---

Matcha is not a treatment for diabetes. It is a drink with measurable, well-documented effects on blood sugar and insulin sensitivity, supported by recent meta-analyses. As part of a balanced diet and a broader management plan, it is one of the more research-backed dietary additions a person with type 2 diabetes can make. If you want to try it, our matcha is single-ingredient, single-origin from Japan, no fillers or sweeteners.

Browse our matcha.

Sources

• Wang, J., et al. (2024). The effect of green tea on patients with type 2 diabetes mellitus: a meta-analysis. Medicine (Baltimore), 103(47).
• Effect of EGCG on glycemic index: a systematic review and meta-analysis of 41 randomised controlled trials (2024). Clinical Therapeutics.
• Huxley, R., et al. (2009). Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Archives of Internal Medicine, 169(22), 2053–2063.
• Venables, M. C., et al. (2008). Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. The American Journal of Clinical Nutrition, 87(3), 778–784.
• Chacko, S. M., et al. (2010). Beneficial effects of green tea: a literature review. Chinese Medicine, 5(1), 13.